Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems
- PMID:25890180
- PMCID: PMC4351689
- DOI: 10.1186/s12958-015-0005-4
Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems
Abstract
Human embryonic stem cells (hESC) have emerged as attractive candidates for cell-based therapies that are capable of restoring lost cell and tissue function. These unique cells are able to self-renew indefinitely and have the capacity to differentiate in to all three germ layers (ectoderm, endoderm and mesoderm). Harnessing the power of these pluripotent stem cells could potentially offer new therapeutic treatment options for a variety of medical conditions. Since the initial derivation of hESC lines in 1998, tremendous headway has been made in better understanding stem cell biology and culture requirements for maintenance of pluripotency. The approval of the first clinical trials of hESC cells for treatment of spinal cord injury and macular degeneration in 2010 marked the beginning of a new era in regenerative medicine. Yet it was clearly recognized that the clinical utility of hESC transplantation was still limited by several challenges. One of the most immediate issues has been the exposure of stem cells to animal pathogens, during hESC derivation and during in vitro propagation. Initial culture protocols used co-culture with inactivated mouse fibroblast feeder (MEF) or human feeder layers with fetal bovine serum or alternatively serum replacement proteins to support stem cell proliferation. Most hESC lines currently in use have been exposed to animal products, thus carrying the risk of xeno-transmitted infections and immune reaction. This mini review provides a historic perspective on human embryonic stem cell culture and the evolution of new culture models. We highlight the challenges and advances being made towards the development of xeno-free culture systems suitable for therapeutic applications.
Similar articles
- Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.Meng G, Liu S, Rancourt DE.Meng G, et al.Stem Cells Dev. 2012 Jul 20;21(11):2036-48. doi: 10.1089/scd.2011.0489. Epub 2012 Jan 26.Stem Cells Dev. 2012.PMID:22149941
- Embryonic stem cells: isolation, characterization and culture.Amit M, Itskovitz-Eldor J.Amit M, et al.Adv Biochem Eng Biotechnol. 2009;114:173-84. doi: 10.1007/10_2008_20.Adv Biochem Eng Biotechnol. 2009.PMID:19495683Review.
- High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos.Ye J, Bates N, Soteriou D, Grady L, Edmond C, Ross A, Kerby A, Lewis PA, Adeniyi T, Wright R, Poulton KV, Lowe M, Kimber SJ, Brison DR.Ye J, et al.Stem Cell Res Ther. 2017 Jun 5;8(1):128. doi: 10.1186/s13287-017-0561-y.Stem Cell Res Ther. 2017.PMID:28583200Free PMC article.
- Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells.Unger C, Gao S, Cohen M, Jaconi M, Bergstrom R, Holm F, Galan A, Sanchez E, Irion O, Dubuisson JB, Giry-Laterriere M, Salmon P, Simon C, Hovatta O, Feki A.Unger C, et al.Hum Reprod. 2009 Oct;24(10):2567-81. doi: 10.1093/humrep/dep232. Epub 2009 Jun 25.Hum Reprod. 2009.PMID:19556288
- Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges.Lei T, Jacob S, Ajil-Zaraa I, Dubuisson JB, Irion O, Jaconi M, Feki A.Lei T, et al.Cell Res. 2007 Aug;17(8):682-8. doi: 10.1038/cr.2007.61.Cell Res. 2007.PMID:17667917Review.
Cited by
- Human embryonic stem cells cultured on hydrogels grafted with extracellular matrix protein-derived peptides with polyethylene glycol joint nanosegments.Alarfaj AA, Hirad AH, Munusamy MA, Kumar SS, Higuchi A.Alarfaj AA, et al.IET Nanobiotechnol. 2022 Dec;16(9):295-304. doi: 10.1049/nbt2.12091. Epub 2022 Oct 6.IET Nanobiotechnol. 2022.PMID:36200801Free PMC article.
- Characterization of dystroglycan binding in adhesion of human induced pluripotent stem cells to laminin-511 E8 fragment.Sugawara Y, Hamada K, Yamada Y, Kumai J, Kanagawa M, Kobayashi K, Toda T, Negishi Y, Katagiri F, Hozumi K, Nomizu M, Kikkawa Y.Sugawara Y, et al.Sci Rep. 2019 Sep 10;9(1):13037. doi: 10.1038/s41598-019-49669-x.Sci Rep. 2019.PMID:31506597Free PMC article.
- Stem Cells and Infertility: A Review of Clinical Applications and Legal Frameworks.Cucinella G, Gullo G, Catania E, Perino A, Billone V, Marinelli S, Napoletano G, Zaami S.Cucinella G, et al.J Pers Med. 2024 Jan 24;14(2):135. doi: 10.3390/jpm14020135.J Pers Med. 2024.PMID:38392569Free PMC article.Review.
- Distinct Metabolic States Can Support Self-Renewal and Lipogenesis in Human Pluripotent Stem Cells under Different Culture Conditions.Zhang H, Badur MG, Divakaruni AS, Parker SJ, Jäger C, Hiller K, Murphy AN, Metallo CM.Zhang H, et al.Cell Rep. 2016 Aug 9;16(6):1536-1547. doi: 10.1016/j.celrep.2016.06.102. Epub 2016 Jul 28.Cell Rep. 2016.PMID:27477285Free PMC article.
- Dental Pulp Stem Cells: Current Advances in Isolation, Expansion and Preservation.Rodas-Junco BA, Villicaña C.Rodas-Junco BA, et al.Tissue Eng Regen Med. 2017 Mar 14;14(4):333-347. doi: 10.1007/s13770-017-0036-3. eCollection 2017 Aug.Tissue Eng Regen Med. 2017.PMID:30603490Free PMC article.Review.
References
- Baharvand H, Jafary H, Massumi M, Ashtiani SK. Generation of insulin-secreting cells from human embryonic stem cells. Dev Growth Differ. 2006;48(5):323–32. - PubMed
- Sundberg M, Andersson PH, Akesson E, Odeberg J, Holmberg L, Inzunza J, et al. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue. Cell Transplant. 2011;20(2):177–91. - PubMed
- Pal R, Mamidi MK, Das AK, Bhonde R. Comparative analysis of cardiomyocyte differentiation from human embryonic stem cells under 3-D and 2-D culture conditions. J Biosci Bioeng. 2013;115(2):200–6. - PubMed
- Miki T, Ring A, Gerlach J. Hepatic differentiation of human embryonic stem cells is promoted by three-dimensional dynamic perfusion culture conditions. Tissue Eng Part C Methods. 2011;17(5):557–68. - PubMed
- Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources